Yichun Forestry Central Hospital Trials

Yichun Forestry Central Hospital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Yao, Jing

NCT05861635: The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Recruiting

RoW

Disitamab Vedotin combined with Tislelizumab

Wuhan Union Hospital, China

Breast Cancer, Neoadjuvant Therapy

02/25

02/26

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases

04/25

NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

Recruiting

360

RoW

PM8002, Nab-Paclitaxel, Placebo

Biotheus Inc.

Triple Negative Breast Cancer(TNBC)

07/27

07/28

ELAINE 3, NCT05696626: Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Recruiting

500

Europe, Canada, US, RoW

Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib

Sermonix Pharmaceuticals Inc.

Metastatic Breast Cancer

04/27

04/28

NCT06000917: A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer

Recruiting

RoW

pyrotinib,Trastuzumab，carboplatin，Albumin paclitaxel

Wuhan Union Hospital, China

Breast Cancer, Neoadjuvant

05/25

05/28

NCT05872347: Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Recruiting

RoW

SPH4336 Tablets

Shanghai Pharmaceuticals Holding Co., Ltd

Breast Cancer Brain Metastases

12/25

MET-LVH, NCT05719337: Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults

Recruiting

N/A

660

RoW

Echocardiography

First Hospital of China Medical University, Wuhan Union Hospital, China

Left Ventricular Hypertrophy

08/24

08/25

NCT05818722: A Multicentre Retrospective Study on Bicuspid Aortic Valve

Recruiting

N/A

1000

RoW

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, Nanjing Children's Hospital

Bicuspid Aortic Valve

12/24

12/25

NCT05633732: Developing Echocardiography Image Quality Management System Based on Deep Learning

Recruiting

N/A

2000

RoW

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Southeast University, China

Echocardiography

12/24

12/25

SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting

N/A

1000

RoW

benralizumab

AstraZeneca

Chronic Obstructive Pulmonary Disease

01/26

Li, Dajun

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25

Diao, Hongyan

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Yao, Jing

NCT05861635: The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Recruiting

RoW

Disitamab Vedotin combined with Tislelizumab

Wuhan Union Hospital, China

Breast Cancer, Neoadjuvant Therapy

02/25

02/26

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25

NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

Recruiting

360

RoW

PM8002, Nab-Paclitaxel, Placebo

Biotheus Inc.

Triple Negative Breast Cancer(TNBC)

07/27

07/28

Recruiting

500

Europe, Canada, US, RoW

Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib

Sermonix Pharmaceuticals Inc.

Metastatic Breast Cancer

04/27

04/28

NCT06000917: A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer

Recruiting

RoW

pyrotinib,Trastuzumab，carboplatin，Albumin paclitaxel

Wuhan Union Hospital, China

Breast Cancer, Neoadjuvant

05/25

05/28

NCT05872347: Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Recruiting

RoW

SPH4336 Tablets

Shanghai Pharmaceuticals Holding Co., Ltd

Breast Cancer Brain Metastases

12/25

MET-LVH, NCT05719337: Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults

Recruiting

N/A

660

RoW

Echocardiography

First Hospital of China Medical University, Wuhan Union Hospital, China

Left Ventricular Hypertrophy

08/24

08/25

NCT05818722: A Multicentre Retrospective Study on Bicuspid Aortic Valve

Recruiting

N/A

1000

RoW

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, Nanjing Children's Hospital

Bicuspid Aortic Valve

12/24

12/25

NCT05633732: Developing Echocardiography Image Quality Management System Based on Deep Learning

Recruiting

N/A

2000

RoW

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Southeast University, China

Echocardiography

12/24

12/25

SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting

N/A

1000

RoW

benralizumab

AstraZeneca

Chronic Obstructive Pulmonary Disease

01/26

Li, Dajun

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25

Diao, Hongyan

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25



	Diseases Companies Products Productz Mechanisms of Action Sites